BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

NCT03762018 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

NETWORK

Sponsor class

Conditions

Pleural Mesothelioma Malignant Advanced

Interventions

DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: Bevacizumab
DRUG: Atezolizumab

Sponsor

ETOP IBCSG Partners Foundation

Collaborators

[object Object]